한글목차

세계 상처 관리 기기 시장은 2024년에 206억 9,000만 달러에 달했습니다. 2033년에는 290억 달러에 달할 것으로 예측되며, 예측 기간인 2025년까지 3.8%의 연평균 복합 성장률(CAGR)을 보일 것으로 예상됩니다.

상처 관리 기기는 급성 상처, 만성 상처, 외과적 상처를 포함한 다양한 유형의 상처를 치료, 치유, 예방하기 위해 고안된 의료 도구입니다. 조기 치유, 감염 위험 감소, 합병증 최소화로 환자 결과를 개선합니다. 이 시장에는 NPT 시스템, 보습 드레싱 재료, 생체공학 제품, 수술용 기기 등의 첨단 솔루션이 포함됩니다. 만성 질환 증가, 인구의 고령화, 그에 따른 외과 수술 증가로 인해 혁신적인 상처 관리 기기에 대한 수요가 증가하고 있습니다.

시장 역학:

성장 촉진요인과 억제요인

만성 상처 증가

당뇨성 족부궤양, 욕창, 정맥성 하지궤양과 같은 만성 상처의 발생률이 증가함에 따라 상처 관리 기기 시장이 활기를 띠고 있습니다. 인구 고령화, 당뇨병 유병률 증가, 비만 등의 요인으로 인해 치유되지 않는 상처가 증가하고 있습니다. 효과적인 치유와 합병증 예방을 위해서는 첨단 솔루션이 필요합니다. 특히 북미와 유럽과 같은 선진 지역에서는 이러한 수요가 혁신적인 장비에 대한 수요를 견인하고 있습니다.

예를 들어, 5년 동안 메디케어 수혜자의 상처 유병률은 820만 명에서 1,050만 명으로 13% 증가했습니다. 가장 많이 증가한 연령대는 65세 미만이었습니다. 가장 큰 변화를 보인 것은 동맥성 궤양, 피부질환, 외상성 상처였습니다. 지출은 세 가지 방법에 관계없이 감소했으며, 가장 보수적인 방법에서는 297억 달러에서 225억 달러로 감소했습니다.

고급 상처 치료 제품의 고비용

음압상처치료 시스템, 생체공학 드레싱 재료 등 첨단 상처 치료 제품 및 치료법의 높은 비용은 특히 중저소득 지역에서 시장 성장을 저해하는 요인으로 작용하고 있습니다. 또한, 의료 서비스 제공업체와 환자들은 기존의 상처 치료 제품들에 대한 제한적인 상환 정책 및 제한으로 인해 기존의 치료법을 선택하는 경향이 있습니다.

목차

제1장 분석 방법이및 분석 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석

제5장 전략적 인사이트와 업계 전망

• 시장 리더와 선구자
  • 새로운 선구자와 주요 기업
  • 최대 판매를 자랑하는 브랜드를 확립한 리더
  • 확립된 제품을 보유한 시장 리더
• CXO 시점
• 최신 개발과 Break through
• 사례 연구/진행 중인 연구
• 규제와 상환 상황
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• Porter의 Five Forces 분석
• 공급망 분석
• 특허 분석
• SWOT 분석
• 미충족 요구와 갭
• 시장 진입 및 확장을 위한 추천 전략
• 시나리오 분석 : 베스트 케이스/베이스 케이스/워스트 케이스 예측
• 가격 분석과 가격 시장 역학
• KOL(Key Opinion Leader)

제6장 제품 유형별

• 첨단 상처 관리 기기
• 외과용 상처 관리 기기
• 기존 상처 관리 기기

제7장 총성 유형별

• 만성 창상
• 급성 창상

제8장 최종사용자별

• 병원 및 진료소
• 재택치료
• 장기 요양시설

제9장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타 유럽
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
• 중동 및 아프리카

제10장 경쟁 구도

• 경쟁 시나리오
• 시장 현황 및 점유율 분석
• 인수합병(M&A) 분석

제11장 기업 개요

• Smith & Nephew plc
  • 기업 개요
  • 제품 포트폴리오
    • 제품 설명
    • 제품 핵심성과지표(KPI)
    • 제품 판매 실적과 예측
    • 제품 판매량
  • 재무 개요
    • 기업 매출
    • 매출 점유율 : 지역별
    • 매출 예측
  • 주요 발전
    • 인수합병(M&A)
    • 주요 제품 개발 활동
    • 규제기관 승인 등
  • SWOT 분석
• 3M Company
• Cardinal Health, Inc.
• Medtronic plc
• Coloplast A/S
• ConvaTec Group plc
• Johnson & Johnson Services, Inc.
• Molnlycke Health Care AB
• Hollister Incorporated
• Medline Industries, Inc
• Similar data will be provided for each market player.
• MiMedx Group, Inc
  • 파이프라인 제품 설명
  • 제품 핵심성과지표(KPI)
  • 주요 활동
  • 시장 참여 타임라인
  • 제품 보급률
  • 판매 예측과 예측
• Talley Group Ltd
• DeRoyal Industries, Inc.
• 각 기업에 대해서도 같은 데이터가 제공됩니다.

제12장 부록

영문목차

The Global wound care management devices market reached US$ 20.69 billion in 2024 and is expected to reach US$ 29.00 billion by 2033, growing at a CAGR of 3.8% during the forecast period 2025-2033.

Wound care management devices are medical tools designed to treat, heal, and prevent various types of wounds, including acute, chronic, and surgical ones. They improve patient outcomes by promoting faster healing, reducing infection risks, and minimizing complications. The market includes advanced solutions like NPT systems, moisture-retentive dressings, bioengineered products, and surgical devices. With the rising incidence of chronic diseases, aging populations, and the subsequent increase in surgical procedures, the demand for innovative wound care management devices is growing.

Market Dynamics: Drivers & Restraints

Increasing Incidence of Chronic Wounds

The market for wound care management devices is booming due to the increasing incidence of chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Factors like an aging population, rising prevalence of diabetes, and obesity contribute to the increasing incidence of non-healing wounds. Advanced solutions are needed for effective healing and preventing complications. This demand, especially in developed regions like North America and Europe, is driving the demand for innovative devices.

For instance, over a 5-year period, Medicare beneficiaries with wounds increased from 8.2 million to 10.5 million, with a 13% increase in wound prevalence. The largest increase was seen in those aged <65 years. The largest changes were in arterial ulcers, skin disorders, and traumatic wounds. Expenditures decreased regardless of the three methods used, with a reduction of $29.7 billion to $22.5 billion for the most conservative method.

High Cost of Advanced Wound Care Products

The high cost of advanced wound care products and therapies, such as negative pressure wound therapy systems and bioengineered dressings, hinders market growth, especially in low and middle-income regions. Limited reimbursement policies and traditional wound care products also limit their adoption, leading healthcare providers and patients to opt for traditional options.

Segment Analysis

The global wound care management devices market is segmented based on product type, wound type, end user and region.

Product Type:

The advanced wound care devices in the product type segment are expected to dominate with the highest market share.

The advanced wound care devices segment holds a major portion of the wound care management devices market share and is expected to continue to hold a significant portion during the forecast period.

Advanced wound care devices, such as negative pressure wound therapy systems, advanced dressings, and bioactive products, are crucial for treating complex and chronic wounds like diabetic foot ulcers, pressure ulcers, and surgical wounds. They facilitate faster healing, reduce infection risks, and minimize patient discomfort. Demand for these devices is growing in North America and Europe due to their effectiveness in promoting wound healing, especially for patients with underlying conditions like diabetes and cardiovascular diseases. As the demand rises, manufacturers are actively involved in the launch of advanced products.

For instance, in February 2025, Biomiq Inc., a leading Canadian provider of advanced wound care solutions, introduced PureGel, a super-oxidizing nano-hydrogel. This Class II medical device offers a long-lasting, non-cytotoxic solution for wound management, marking a new era in advanced wound care.

Geographical Analysis

North America is expected to hold a significant position in the wound care management devices market share.

North America holds a substantial position in the wound care management devices market and is expected to hold most of the market share in the future. This dominance is fuelled by the increasing prevalence of chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The region's high diabetes and obesity rates necessitate advanced wound care solutions. The presence of established healthcare infrastructure, increasing healthcare expenditure, and advanced wound care technologies drive market growth.

For instance, in May 2024, AVITA Medical, a regenerative medicine company, received FDA approval for its premarket approval supplement for the RECELL GO System, a next-generation autologous cell harvesting device that uses a patient's own skin's regenerative properties to treat thermal burn wounds and full-thickness skin defects.

Competitive Landscape

The major global players in the wound care management devices market include Smith & Nephew plc, 3M Company, Cardinal Health, Inc., Medtronic plc, Coloplast A/S, ConvaTec Group plc, Johnson & Johnson Services, Inc., Molnlycke Health Care AB, Hollister Incorporated, Medline Industries, Inc., and among others.

Key Developments

• In September 2024, Solventum launched the V.A.C. Peel and Place Dressing, an integrated dressing and drape that can be applied in less than two minutes and worn by patients for up to seven days. Traditional dressings for negative pressure wound therapy take longer, require a multi-step process, and may need to be changed three times a week.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Wound Care Management Devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Wound Type
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Chronic Wounds
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Advanced Wound Care Products
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa
• 5.6. Porter's Five Forces Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index by Product Type
• 6.2. Advanced Wound Care Devices*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Surgical Wound Care Devices
• 6.4. Traditional Wound Care Devices

7. By Wound Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
  • 7.1.2. Market Attractiveness Index by Wound Type
• 7.2. Chronic Wounds*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Acute Wounds

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals and Clinics*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Home Healthcare
• 8.4. Long-term Care Facilities

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

• 11.1. Smith & Nephew plc*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals, etc.
  • 11.1.5. SWOT Analysis
• 11.2. 3M Company
• 11.3. Cardinal Health, Inc.
• 11.4. Medtronic plc
• 11.5. Coloplast A/S
• 11.6. ConvaTec Group plc
• 11.7. Johnson & Johnson Services, Inc.
• 11.8. Molnlycke Health Care AB
• 11.9. Hollister Incorporated
• 11.10. Medline Industries, Inc
• Similar data will be provided for each market player.

Emerging Market Players

• 11.11. MiMedx Group, Inc*
  • 11.11.1. Pipeline Products Description
  • 11.11.2. Product Key Performance Indicators (KPIs)
  • 11.11.3. Key Activities
  • 11.11.4. Market Entry Timelines
  • 11.11.5. Product Penetration Rate
  • 11.11.6. Sales Estimation and Projections
• 11.12. Talley Group Ltd
• 11.13. DeRoyal Industries, Inc.
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us